Olfoxacin Otic Soln
- Product NDC
- 72189-490
- 11-digit product format
- 721890490
- Labeler code
- 72189
- Product ID
- 72189-490_4d3aa53c-878c-d447-e063-6394a90a6a31
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olfoxacin Otic Soln
- Dosage form
- SOLUTION
- Route
- AURICULAR (OTIC)
- Labeler
- Direct_Rx
- Application
- ANDA216130
- Marketing category
- ANDA
- Marketing start
- 2023-06-08
- Substance
- OFLOXACIN
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Quinolone Antimicrobial [EPC], Quinolones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72189-490-05 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72189-490-05 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216130-001 | OFLOXACIN | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216130-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | e64feba35796… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216130-001 | OFLOXACIN | 0.3% | SOLUTION/DROPS / OTIC | AT | 2022-07-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A216130-001 | AT | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A216130-001 | AT | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A216130-001 | AT | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A216130-001 | AT | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A216130-001 | AT | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A216130-001 | AT | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A216130-001 | AT | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A216130-001 | AT | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A216130-001 | AT | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A216130-001 | AT | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A216130-001 | AT | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A216130-001 | AT | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A216130-001 | AT | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A216130-001 | AT | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A216130-001 | AT | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A216130-001 | AT | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A216130-001 | AT | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A216130-001 | AT | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A216130-001 | AT | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A216130-001 | AT | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A216130-001 | AT | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A216130-001 | AT | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A216130-001 | AT | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A216130-001 | AT | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A216130-001 | AT | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A216130-001 | AT | 1 | e64feba35796… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A216130-001 | AT | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olfoxacin Otic Soln
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OFLOXACIN | 3 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| A4P49JAZ9H | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 242446 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| fda35d37-f36a-efc8-e053-6294a90a2bb8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f9d82093-3de1-4841-9a42-67222d61a0cf | Product name | 4 | 20250515 |
| bbed5f06-a6b7-a443-70ac-77518a9524b7 | Product name | 7 | 20250311 |
| 41679fed-052c-574b-6b40-cadcbc315b79 | Product name | 2 | 20150401 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-490-05 | Olfoxacin Otic Soln | 5 mL in 1 BOTTLE, DROPPER | SOLUTION | 5 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-490-05 | ML - Milliliter | 72189-490 | d11f3af3-860e-4404-b1bb-4792ee3a3a1a | 1 | 2023-07-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ofloxacin | OFLOXACIN OTIC | Sportpharm LLC | 3f5972db-4eaf-4237-944d-8f63eff7b9b1 | 2026-06-26 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | REMEDYREPACK INC. | fe619d50-49bf-4fcc-9428-6108c45580eb | 2026-06-11 | Warnings, Adverse reactions | 216130 ANDA216130 |
| Olfoxacin Otic Soln | OLFOXACIN OTIC SOLN | Direct_Rx | fda35d37-f36a-efc8-e053-6294a90a2bb8 | 2026-03-17 | Warnings, Adverse reactions | 216130 ANDA216130 72189-490 |
| ofloxacin | OFLOXACIN OTIC | A-S Medication Solutions | 71949588-42e2-446c-b7ec-904c09b2f95f | 2024-08-07 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | NuCare Pharmaceuticals,Inc. | 1e917318-cdc7-cd2c-e063-6294a90a0cc2 | 2024-08-02 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | Asclemed USA, Inc. | ff2abdd2-f7ca-49cd-a2d6-cd2bbd980b0c | 2024-06-12 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | Proficient Rx LP | 79074efc-83ed-4473-bb86-9f635928ea92 | 2024-03-01 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | NorthStar RxLLC | b95114f6-6753-4217-b621-44fa34afc298 | 2023-10-06 | Warnings, Adverse reactions | 216130 ANDA216130 |
| ofloxacin | OFLOXACIN OTIC | Lifestar Pharma LLC | 0621700e-6315-47ff-a8ed-cccf7d6fc56a | 2023-06-23 | Warnings, Adverse reactions | 216130 ANDA216130 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 242446 | ofloxacin 0.3 % Otic Solution | PSN | fda35d37-f36a-efc8-e053-6294a90a2bb8 | 3 |
| 242446 | ofloxacin 3 MG/ML Otic Solution | SCD | fda35d37-f36a-efc8-e053-6294a90a2bb8 | 3 |
| 242446 | ofloxacin 0.3 % Otic Solution | SY | fda35d37-f36a-efc8-e053-6294a90a2bb8 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72189-490-05 | 72189049005 | 5 mL in 1 BOTTLE, DROPPER (72189-490-05) | 5 ml | 2023-06-08 | No | No | Current |